Level Biotechnology Inc. Statistics
Level Biotechnology Inc. (3118) Stock Statistics & Valuation Metrics
Total Valuation
Level Biotechnology Inc. has a market cap or net worth of TWD 983.32M. The enterprise value is TWD 846.49M.
- Market Cap
- TWD 983.32M
- Enterprise Value
- TWD 846.49M
Share Statistics
Level Biotechnology Inc. has 32,452,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 32,452,860
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Level Biotechnology Inc.’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 11.44%.
- Return on Equity (ROE)
- 0.14
- Return on Assets (ROA)
- 0.09
- Return on Invested Capital (ROIC)
- 11.44%
- Return on Capital Employed (ROCE)
- 0.14
- Revenue Per Employee
- 5.75M
- Profits Per Employee
- 622.65K
- Employee Count
- 128
- Asset Turnover
- 0.85
- Inventory Turnover
- 4.26
Valuation Ratios
The current PE Ratio of Level Biotechnology Inc. is 12.89. Level Biotechnology Inc.’s PEG ratio is 1.19.
- PE Ratio
- 12.89
- PS Ratio
- 1.39
- PB Ratio
- 1.82
- Price to FCF
- 12.61
- Price to Operating Cash Flow
- 10.54
- PEG Ratio
- 1.19
Income Statement
In the last 12 months, Level Biotechnology Inc. had revenue of 736.59M and earned 79.70M in profits. Earnings per share was 2.46.
- Revenue
- 736.59M
- Gross Profit
- 244.31M
- Operating Income
- 83.55M
- Pretax Income
- 97.58M
- Net Income
- 79.70M
- EBITDA
- 106.00M
- Earnings Per Share (EPS)
- 2.46
Cash Flow
In the last 12 months, operating cash flow was 93.28M and capital expenditures -15.31M, giving a free cash flow of 77.98M billion.
- Operating Cash Flow
- 93.28M
- Free Cash Flow
- 77.98M
- Free Cash Flow per Share
- 2.40
Dividends & Yields
Level Biotechnology Inc. pays an annual dividend of ―, resulting in a dividend yield of 7.26%
- Dividend Per Share
- ―
- Dividend Yield
- 7.26%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 7.93%
- Earnings Yield
- 7.73%
Stock Price Statistics
- Beta
- 0.12
- 52-Week Price Change
- -10.75%
- 50-Day Moving Average
- 31.13
- 200-Day Moving Average
- 31.33
- Relative Strength Index (RSI)
- 27.72
- Average Volume (3m)
- 16.69K
Important Dates
Level Biotechnology Inc. upcoming earnings date is Nov 10, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 07, 2026
- Next Earnings Date
- Nov 10, 2026
- Ex-Dividend Date
- ―
Financial Position
Level Biotechnology Inc. as a current ratio of 1.82, with Debt / Equity ratio of 1.38%
- Current Ratio
- 1.82
- Quick Ratio
- 1.40
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -1.91
- Interest Coverage Ratio
- 417.73
Taxes
In the past 12 months, Level Biotechnology Inc. has paid 17.88M in taxes.
- Income Tax
- 17.88M
- Effective Tax Rate
- 0.18
Enterprise Valuation
Level Biotechnology Inc. EV to EBITDA ratio is 7.21, with an EV/FCF ratio of 10.20.
- EV to Sales
- 1.12
- EV to EBITDA
- 7.21
- EV to Free Cash Flow
- 10.20
- EV to Operating Cash Flow
- 8.53
Balance Sheet
Level Biotechnology Inc. has TWD 195.38M in cash and marketable securities with TWD 7.38M in debt, giving a net cash position of TWD 188.00M billion.
- Cash & Marketable Securities
- TWD 195.38M
- Total Debt
- TWD 7.38M
- Net Cash
- TWD 188.00M
- Net Cash Per Share
- TWD 5.79
- Tangible Book Value Per Share
- TWD 16.63
Margins
Gross margin is 34.37%, with operating margin of 12.04%, and net profit margin of 10.72%.
- Gross Margin
- 34.37%
- Operating Margin
- 12.04%
- Pretax Margin
- 13.22%
- Net Profit Margin
- 10.72%
- EBITDA Margin
- 15.55%
- EBIT Margin
- 12.28%
Analyst Forecast
The average price target for Level Biotechnology Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -3.54%
- EPS Growth Forecast
- 10.34%
